Warwick Dunn

Dr. Warwick Dunn


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2011 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
TCThe Human Serum Metabolome (HUSERMET) Consortium
The Human Serum Metabolome (HUSERMET) Consortium
WDWarwick Dunn
Warwick Dunn
DBDavid I Broadhurst
David I Broadhurst
PBPaul Begley
Paul Begley
EZEva Zelena
Eva Zelena
RGRoyston Goodacre
Royston Goodacre

3 March 2013 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
ITInes Thiele
Ines Thiele
NSNeil Swainston
Neil Swainston
RFRonan MT Fleming
Ronan MT Fleming
AHAndreas Hoppe
Andreas Hoppe
SSSwagatika Sahoo
Swagatika Sahoo
BPBernhard Ø Palsson
Bernhard Ø Palsson
The metabolic modeling community has curated information from five models to create the most comprehensive model of human metabolism to date. Multiple models of human metabolism have been reconstructed, but each represents only a subset of our knowledge. Here we describe Recon 2, a community-driven, consensus 'metabolic reconstruction', which is the most comprehensive representation of human metabolism that is applicable to computational modeling. Compared with its predecessors, the reconstruction has improved topological and functional features, including ∼2× more reactions and ∼1.7× more unique metabolites. Using Recon 2 we predicted changes in metabolite biomarkers for 49 inborn errors of metabolism with 77% accuracy when compared to experimental data. Mapping metabolomic data and drug information onto Recon 2 demonstrates its potential for integrating and analyzing diverse data types. Using protein expression data, we automatically generated a compendium of 65 cell type–specific models, providing a basis for manual curation or investigation of cell-specific metabolic properties. Recon 2 will facilitate many future biomedical studies and is freely available at http://humanmetabolism.org/ .

1 April 2005 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
WDWarwick Dunn
Warwick Dunn
David EllisDavid Ellis
David Ellis

18 May 2018 in Metabolomics
Verified
Journal Article
Open access
PDF file
DBDavid I Broadhurst
David I Broadhurst
RGRoyston Goodacre
Royston Goodacre
SRStacey Reinke
Stacey Reinke
Julia KuligowskiJulia Kuligowski
Julia Kuligowski
Ian WilsonIan Wilson
Ian Wilson
WDWarwick Dunn
Warwick Dunn
Background Quality assurance (QA) and quality control (QC) are two quality management processes that are integral to the success of metabolomics including their application for the acquisition of high quality data in any high-throughput analytical chemistry laboratory. QA defines all the planned and systematic activities implemented before samples are collected, to provide confidence that a subsequent analytical process will fulfil predetermined requirements for quality. QC can be defined as the operational techniques and activities used to measure and report these quality requirements after data acquisition. Aim of review This tutorial review will guide the reader through the use of system suitability and QC samples, why these samples should be applied and how the quality of data can be reported. Key scientific concepts of review System suitability samples are applied to assess the operation and lack of contamination of the analytical platform prior to sample analysis. Isotopically-labelled internal standards are applied to assess system stability for each sample analysed. Pooled QC samples are applied to condition the analytical platform, perform intra-study reproducibility measurements (QC) and to correct mathematically for systematic errors. Standard reference materials and long-term reference QC samples are applied for inter-study and inter-laboratory assessment of data.

26 January 2009 in Analytical Chemistry
Verified
Journal Article
Closed access
EZEva Zelena
Eva Zelena
WDWarwick Dunn
Warwick Dunn
DBDavid I Broadhurst
David I Broadhurst
SFSue Francis-McIntyre
Sue Francis-McIntyre
KCKathleen M. Carroll
Kathleen M. Carroll
DKDouglas Kell
Douglas Kell

1 January 2011 in Chemical Society Reviews
Verified
Journal Article
Closed access
WDWarwick Dunn
Warwick Dunn
DBDavid I Broadhurst
David I Broadhurst
HAHelen J. Atherton
Helen J. Atherton
RGRoyston Goodacre
Royston Goodacre
JGJulian L. Griffin
Julian L. Griffin
The study of biological systems in a holistic manner (systems biology) is increasingly being viewed as a necessity to provide qualitative and quantitative descriptions of the emergent properties of the complete system. Systems biology performs studies focussed on the complex interactions of system components; emphasising the whole system rather than the individual parts. Many perturbations to mammalian systems (diet, disease, drugs) are multi-factorial and the study of small parts of the system is insufficient to understand the complete phenotypic changes induced. Metabolomics is one functional level tool being employed to investigate the complex interactions of metabolites with other metabolites (metabolism) but also the regulatory role metabolites provide through interaction with genes, transcripts and proteins (e.g. allosteric regulation). Technological developments are the driving force behind advances in scientific knowledge. Recent advances in the two analytical platforms of mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy have driven forward the discipline of metabolomics. In this critical review, an introduction to metabolites, metabolomes, metabolomics and the role of MS and NMR spectroscopy will be provided. The applications of metabolomics in mammalian systems biology for the study of the health-disease continuum, drug efficacy and toxicity and dietary effects on mammalian health will be reviewed. The current limitations and future goals of metabolomics in systems biology will also be discussed (374 references).